Screener
Dyne Therapeutics, Inc. DYN EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026. Open the filing →
- Filed
- May 11, 2026, 7:25 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215702
FAQ
- What is Dyne Therapeutics, Inc.'s EPS (diluted)?
- Dyne Therapeutics, Inc. (DYN) reported EPS (diluted) of -$0.73 in Q1 2026.
- How has Dyne Therapeutics, Inc.'s EPS (diluted) changed year-over-year?
- Dyne Therapeutics, Inc.'s EPS (diluted) increased by 30.5% year-over-year, from -$1.05 to -$0.73.
- What is the long-term trend for Dyne Therapeutics, Inc.'s EPS (diluted)?
- Over 4 years (2021 to 2025), Dyne Therapeutics, Inc.'s EPS (diluted) has grown at a 4.7% compound annual growth rate (CAGR), from -$2.92 to -$3.51.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Dyne Therapeutics, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude